许晟尧

作者: 时间:2026-08-05 点击数:


教育及工作经历:

2026年9月起    厦门大学生命科学学院生物化学与分子生物学专业博士研究生,导师:刘刚教授。

2023年9月-2026年6月    沈阳药科大学无涯创新学院药剂学专业,获硕士学位,导师:孙丙军教授。

代表性成果:

Shengyao Xu#, Danping Wang#, Si Zheng, Zhiyu Kuang, Ya Gao, Haiyu Zhao, Lurong Zhang, Jiayu Guo, Jingyi Zhang, Weiyao Li, Anhua Wang, Hongrui Lei, Zhonggui He, Ken‐ichiro Kamei, Jianzhao Niu*, Lingyun Ma*, Bingjun Sun*, Tailoring drug-to-lipid ratio in redox-responsive lipid-mimetic prodrug liposomes for superior cabazitaxel delivery and antitumor efficacy. BMEMat, 2026, e70122.

Danping Wang, Shengyao Xu, Si Zheng, Rong Chai, Zhiyu Kuang, Yixin Sun, Yaqi Li, Shiyi Zuo, Xiang Gao, Xin Li, Qikun Jiang, Zhonggui He, Jin Sun, Hongrui Lei*, Anhua Wang*, Bingjun Sun*, Phospholipid-Like Prodrug Liposomes with High Drug-carrier Affinity and High Tumor Selectivity: Strong Competitors of Paclitaxel Nanomedicines. Advanced Functional Materials, 2026, 36(1): e02341.

Copyright© 2020  刘刚教授课题组    All Rights Reserved.
课题组地址:厦门市翔安区翔安南路厦门大学公共卫生学院分子影像楼308室